Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.51 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.45.
Market Cap
9.51T
Revenue
4.67T
Profits
188.51B
PE Ratio
50.45
Profit Margin
4.04%
Dividend Yield
0.39%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.12T | 3.55% | 3,752,036 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 610.38B | -0.25% | 9,276,715 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 500.80B | 0.59% | 7,621,136 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.02B | 2.79% | 10,161,995 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 358.21B | -1.48% | 13,854,847 | 66.57B |
| 6 | NVS | Novartis AG | 295.33B | 2.38% | 614,558 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 260.99B | 2.87% | 4,412,008 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 257.53B | 3.46% | 3,962,854 | 46.34B |
| 9 | AMGN | Amgen Inc. | 234.65B | 1.86% | 4,599,706 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 195.13B | 2.49% | 8,286,976 | 30.46B |
| 11 | ABT | Abbott Laboratories | 181.14B | 2.29% | 12,747,294 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 174.66B | 2.89% | 2,288,469 | 50.34B |
| 13 | PFE | Pfizer Inc. | 167.80B | 0.79% | 32,876,116 | 63.70B |
| 14 | DHR | Danaher Corporation | 162.74B | 3.03% | 5,227,705 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.15B | 1.81% | 2,060,355 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.95B | 2.06% | 2,262,513 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.73B | 2.18% | 13,753,923 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.41B | 2.42% | 2,900,438 | 412.65B |
| 19 | MDT | Medtronic plc | 116.84B | 1.29% | 50,230,129 | 37.54B |
| 20 | MCK | McKesson Corporation | 116.43B | 2.26% | 728,557 | 410.98B |
| 21 | SYK | Stryker Corporation | 112.48B | 4.12% | 771,803 | 25.84B |
| 22 | GSK | GSK plc | 101.60B | 2.40% | 1,469,112 | 44.05B |
| 23 | HCA | HCA Healthcare, Inc. | 101.43B | -0.41% | 272,458 | 78.01B |
| 24 | SNY | Sanofi | 98.12B | 1.31% | 5,053,585 | 55.89B |
| 25 | MRNA | Moderna, Inc. | 94.42B | 4.51% | 17,347,823 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 92.91B | 0.08% | 1,517,369 | 201.11B |
| 27 | CI | The Cigna Group | 78.96B | 3.19% | 484,979 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 77.72B | 2.31% | 798,815 | 15.53B |
| 29 | COR | Cencora, Inc. | 65.15B | 1.56% | 423,727 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 63.97B | 2.65% | 15,862,112 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 62.43B | 2.31% | 798,248 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 58.75B | 2.41% | 687,626 | 254.25B |
| 33 | NTRA | Natera, Inc. | 58.35B | 2.54% | 1,206,923 | 2.71B |
| 34 | ARGX | argenx SE | 53.15B | 3.42% | 510,744 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.78B | 2.58% | 421,670 | 22.48B |
| 36 | HUM | Humana Inc. | 51.90B | 1.12% | 249,058 | 145.68B |
| 37 | EW | Edwards Lifesciences Corporation | 50.78B | 1.91% | 4,681,091 | 6.51B |
| 38 | VEEV | Veeva Systems Inc. | 50.68B | 5.27% | 596,549 | 3.46B |
| 39 | A | Agilent Technologies, Inc. | 49.49B | 0.89% | 1,893,862 | 7.37B |
| 40 | MDLN | Medline Inc. | 48.08B | 1.78% | 7,660,088 | 29.94B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 47.91B | 0.96% | 1,525,566 | 17.32B |
| 42 | HLN | Haleon plc | 44.93B | 2.69% | 2,986,868 | 14.80B |
| 43 | IQV | IQVIA Holdings Inc. | 44.61B | 3.45% | 418,954 | 16.98B |
| 44 | WAT | Waters Corporation | 43.64B | 1.73% | 276,991 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 43.11B | 3.43% | 545,237 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.53B | 6.43% | 744,814 | 6.13B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.57B | -2.20% | 1,568,318 | - |
| 48 | ILMN | Illumina, Inc. | 40.46B | -1.41% | 2,989,234 | 4.49B |
| 49 | CNC | Centene Corporation | 34.83B | 0.50% | 878,519 | 180.30B |
| 50 | BIIB | Biogen Inc. | 34.77B | 1.08% | 1,572,060 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 34.28B | 1.07% | 3,407,011 | 2.54B |
| 52 | RMD | ResMed Inc. | 34.07B | 2.95% | 352,424 | 5.65B |
| 53 | ALC | Alcon Inc. | 33.48B | 4.24% | 650,519 | 10.86B |
| 54 | DXCM | DexCom, Inc. | 33.10B | 5.08% | 4,786,160 | 4.97B |
| 55 | MTD | Mettler-Toledo International Inc. | 32.84B | 1.85% | 75,188 | 4.13B |
| 56 | ZTS | Zoetis Inc. | 32.40B | 4.16% | 5,028,896 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.78B | 2.75% | 3,747,777 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.32B | 4.26% | 1,257,389 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.96B | 2.23% | 390,444 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.40B | 2.45% | 261,356 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.36B | 2.44% | 158,402 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 25.37B | 1.96% | 212,247 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.59B | 1.25% | 4,565,908 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.23B | 0.27% | 545,392 | 3.15B |
| 65 | INCY | Incyte Corporation | 22.96B | 1.52% | 1,940,492 | 5.82B |
| 66 | BNTX | BioNTech SE | 22.66B | 1.74% | 1,079,902 | 3.03B |
| 67 | GMAB | Genmab A/S | 22.65B | 2.52% | 4,084,001 | 4.13B |
| 68 | GH | Guardant Health, Inc. | 22.26B | 1.77% | 1,322,217 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.15B | 1.30% | 226,610 | 21.81B |
| 70 | STE | STERIS plc | 21.87B | 3.25% | 317,665 | 6.04B |
| 71 | INSM | Insmed Incorporated | 21.67B | 1.45% | 3,346,590 | 1.14B |
| 72 | VTRS | Viatris Inc. | 20.93B | 4.47% | 8,384,487 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.00B | 2.84% | 1,388,111 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.55B | 1.94% | 391,767 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 17.26B | 1.70% | 602,693 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.57B | 3.02% | 2,774,090 | 2.44B |
| 77 | SOLV | Solventum Corporation | 14.96B | 0.69% | 326,654 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.88B | -0.17% | 403,965 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.62B | 1.40% | 254,077 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.92B | 0.77% | 1,379,140 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.92B | 2.28% | 886,415 | 4.60B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 13.79B | 4.01% | 2,470,003 | 1.66B |
| 83 | ICLR | ICON Public Limited Company | 13.51B | 3.65% | 795,766 | 8.29B |
| 84 | BAX | Baxter International Inc. | 13.32B | 3.87% | 1,136,390 | 11.47B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.12B | 3.37% | 2,638,802 | 713.07M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.99B | -1.56% | 2,019,836 | 14.37B |
| 87 | TEM | Tempus AI, Inc. | 12.83B | 4.11% | 985,263 | 1.43B |
| 88 | SNN | Smith & Nephew plc | 12.65B | 4.34% | 432,467 | 6.30B |
| 89 | PEN | Penumbra, Inc. | 12.65B | 0.34% | 94,121 | 1.50B |
| 90 | EHC | Encompass Health Corporation | 12.60B | 0.96% | 287,400 | 6.21B |
| 91 | SMMT | Summit Therapeutics Inc. | 12.29B | 1.59% | 4,728,461 | - |
| 92 | CORT | Corcept Therapeutics Incorporated | 12.26B | -2.46% | 668,355 | 830.81M |
| 93 | DVA | DaVita Inc. | 12.06B | 4.68% | 625,060 | 14.01B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.76B | 4.39% | 1,962,752 | 5.02B |
| 95 | FMS | Fresenius Medical Care AG | 11.72B | 2.74% | 211,155 | 22.19B |
| 96 | TECH | Bio-Techne Corporation | 11.37B | 0.03% | 2,403,822 | 1.22B |
| 97 | MOH | Molina Healthcare, Inc. | 11.07B | 1.58% | 243,795 | 42.47B |
| 98 | UHS | Universal Health Services, Inc. | 11.04B | 0.79% | 123,856 | 18.11B |
| 99 | COO | The Cooper Companies, Inc. | 10.91B | 4.59% | 777,024 | 4.24B |
| 100 | AVTR | Avantor, Inc. | 10.88B | 2.48% | 1,570,398 | 6.56B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | 1.65% | 2,922,494 | 3.41B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | 1.18% | 2,333,740 | 3.50B |
| 103 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.62B | -0.04% | 266,162 | 1.28B |
| 104 | ALGN | Align Technology, Inc. | 10.61B | 3.39% | 1,140,788 | 4.14B |
| 105 | IBRX | ImmunityBio, Inc. | 10.60B | 0.91% | 19,968,468 | 165.79M |
| 106 | GMED | Globus Medical, Inc. | 10.59B | 3.32% | 619,869 | 3.14B |
| 107 | RGEN | Repligen Corporation | 10.39B | 3.35% | 1,042,750 | 785.10M |
| 108 | OSCR | Oscar Health, Inc. | 10.32B | -2.48% | 5,097,725 | 15.32B |
| 109 | ENSG | The Ensign Group, Inc. | 10.29B | 1.29% | 343,795 | 5.49B |
| 110 | PCVX | Vaxcyte, Inc. | 10.27B | -3.38% | 2,448,336 | - |
| 111 | KRYS | Krystal Biotech, Inc. | 9.77B | -0.21% | 288,015 | 440.48M |
| 112 | GKOS | Glaukos Corporation | 9.76B | -1.36% | 217,824 | 612.84M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.75B | 0.66% | 60,125 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.69B | 1.67% | 963,206 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.62B | 3.61% | 484,654 | 3.05B |
| 116 | QGEN | Qiagen N.V. | 9.55B | 1.34% | 455,270 | 2.10B |
| 117 | TXG | 10x Genomics, Inc. | 9.43B | -0.97% | 4,316,521 | 616.91M |
| 118 | TWST | Twist Bioscience Corporation | 9.06B | -2.48% | 3,542,663 | 431.80M |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 1.23% | 820,991 | 105.00M |
| 120 | CAI | Caris Life Sciences, Inc. | 8.98B | 4.97% | 3,553,104 | 989.61M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.89B | 0.77% | 1,665,140 | 67.67M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.84B | 0.20% | 707,725 | 281.99M |
| 123 | BRKR | Bruker Corporation | 8.61B | 1.69% | 2,106,395 | 3.50B |
| 124 | AXSM | Axsome Therapeutics, Inc. | 8.47B | -0.27% | 802,585 | 776.57M |
| 125 | HNGE | Hinge Health, Inc. | 8.47B | -0.04% | 330,816 | 720.06M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.26B | 0.22% | 2,009,561 | 669.50M |
| 127 | ABVX | ABIVAX Société Anonyme | 8.00B | 5.00% | 1,520,153 | 5.33M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.00% | 1,808,489 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.90B | 3.32% | 359,527 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.65B | 2.94% | 735,475 | 1.36B |
| 131 | PACS | PACS Group, Inc. | 7.56B | 6.16% | 1,697,655 | 5.55B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 7.49B | 1.87% | 1,148,026 | - |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.33B | 3.33% | 2,529,489 | 874.09M |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 6.93B | 3.86% | 632,938 | 7.46M |
| 135 | HIMS | Hims & Hers Health, Inc. | 6.85B | 5.99% | 16,298,851 | 2.58B |
| 136 | ALKS | Alkermes plc | 6.73B | 2.61% | 1,976,641 | 1.67B |
| 137 | GRFS | Grifols, S.A. | 6.72B | 4.14% | 907,078 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.71B | 0.44% | 22,550 | 2.60B |
| 139 | AMRX | Amneal Pharmaceuticals, Inc. | 6.70B | 1.85% | 4,449,211 | 3.12B |
| 140 | IOVA | Iovance Biotherapeutics, Inc. | 6.67B | 3.59% | 2,390,349 | 324.97M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.01% | 866,484 | 1.56B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.24B | 1.40% | 1,440,738 | 840.85M |
| 143 | BLTE | Belite Bio, Inc | 6.15B | -0.07% | 195,857 | - |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 1.45% | 644,557 | 239.92M |
| 145 | GRAL | GRAIL, Inc. | 6.05B | -3.04% | 701,174 | 165.26M |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 1.19% | 332,108 | 290.54M |
| 147 | BLCO | Bausch + Lomb Corporation | 5.95B | 3.87% | 242,937 | 5.32B |
| 148 | IMVT | Immunovant, Inc. | 5.68B | -1.40% | 1,649,270 | - |
| 149 | DOCS | Doximity, Inc. | 5.61B | 5.28% | 1,133,965 | 655.57M |
| 150 | RDNT | RadNet, Inc. | 5.54B | 1.81% | 461,298 | 2.27B |
| 151 | KOD | Kodiak Sciences Inc. | 5.53B | 8.67% | 1,394,380 | - |
| 152 | HAE | Haemonetics Corporation | 5.52B | 0.15% | 230,327 | 1.35B |
| 153 | CGON | CG Oncology, Inc. | 5.49B | 0.15% | 1,186,400 | 6.23M |
| 154 | TFX | Teleflex Incorporated | 5.43B | 4.00% | 317,770 | 2.25B |
| 155 | WAY | Waystar Holding Corp. | 5.41B | 5.10% | 3,547,031 | 1.21B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.35B | 3.04% | 605,232 | 618.07M |
| 157 | MMSI | Merit Medical Systems, Inc. | 5.35B | 2.75% | 707,235 | 1.58B |
| 158 | STVN | Stevanato Group S.p.A. | 5.26B | -0.31% | 147,610 | 1.40B |
| 159 | ERAS | Erasca, Inc. | 5.20B | 1.16% | 8,481,000 | - |
| 160 | SHC | Sotera Health Company | 5.16B | 1.92% | 2,430,662 | 1.22B |
| 161 | COGT | Cogent Biosciences, Inc. | 5.12B | 4.83% | 3,039,760 | - |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.09B | 2.21% | 1,051,889 | 1.01B |
| 163 | MMED | MiniMed Group, Inc. | 5.06B | 7.08% | 27,732,869 | 3.22B |
| 164 | CON | Concentra Group Holdings Parent, Inc. | 4.99B | 4.51% | 340,828 | 2.29B |
| 165 | CRSP | CRISPR Therapeutics AG | 4.98B | 2.59% | 1,351,150 | 13.39M |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.98B | -0.90% | 1,980,593 | 591.33M |
| 167 | SRRK | Scholar Rock Holding Corporation | 4.95B | 2.63% | 1,944,684 | - |
| 168 | ORKA | Oruka Therapeutics, Inc. | 4.89B | -3.66% | 1,222,105 | - |
| 169 | BLLN | BillionToOne, Inc. | 4.85B | 4.96% | 426,227 | 397.41M |
| 170 | MANE | Veradermics, Incorporated | 4.81B | 1.41% | 170,813 | - |
| 171 | LFST | LifeStance Health Group, Inc. | 4.73B | -1.20% | 1,096,751 | 1.58B |
| 172 | RGC | Regencell Bioscience Holdings Limited | 4.72B | 17.39% | 1,912,429 | - |
| 173 | OPCH | Option Care Health, Inc. | 4.68B | 0.32% | 4,029,838 | 5.69B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.60B | 0.06% | 1,740,496 | - |
| 175 | HTFL | HeartFlow, Inc. | 4.43B | 2.92% | 1,423,798 | 212.07M |
| 176 | LIVN | LivaNova PLC | 4.32B | 3.18% | 737,976 | 1.47B |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | 0.09% | 95,456 | 1.84B |
| 178 | ICUI | ICU Medical, Inc. | 4.18B | 2.79% | 239,470 | 2.16B |
| 179 | DNTH | Dianthus Therapeutics, Inc. | 4.16B | -0.49% | 943,572 | 1.90M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.15B | 3.19% | 1,837,465 | - |
| 181 | ABCL | AbCellera Biologics Inc. | 4.11B | 2.51% | 982,581 | 66.17M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -0.16% | 1,734,425 | 308.08M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 3.97B | -1.58% | 1,751,172 | 1.33B |
| 184 | NHC | National HealthCare Corporation | 3.85B | 4.71% | 26,540 | 1.56B |
| 185 | LEGN | Legend Biotech Corporation | 3.84B | 3.99% | 1,574,416 | 1.27B |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.83B | 2.30% | 2,903,874 | 53.81M |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.79B | 1.41% | 2,117,110 | 10.35M |
| 188 | NVST | Envista Holdings Corporation | 3.77B | 2.98% | 811,017 | 2.86B |
| 189 | ARQT | Arcutis Biotherapeutics, Inc. | 3.66B | 10.19% | 3,955,456 | 463.98M |
| 190 | OGN | Organon & Co. | 3.61B | 0.15% | 640,758 | 6.13B |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.60B | 3.11% | 371,351 | 825.34M |
| 192 | VCYT | Veracyte, Inc. | 3.57B | 2.02% | 1,227,165 | 561.90M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.55B | -0.75% | 215,491 | 890.79M |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.47B | 2.29% | 882,645 | -665.00K |
| 195 | CDNA | CareDx, Inc. | 3.45B | 3.07% | 1,302,244 | 458.09M |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | 2.39% | 1,766,946 | 1.14B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.32B | 1.27% | 1,617,856 | 7.50M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | -0.03% | 1,341,844 | 234.13M |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.25B | -1.58% | 425,629 | 1.19M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.19B | 7.46% | 5,216,042 | - |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | -1.80% | 1,407,349 | 606.33M |
| 202 | LQDA | Liquidia Corporation | 3.11B | 2.47% | 7,222,725 | 450.91M |
| 203 | PBLS | Parabilis Medicines, Inc. | 3.11B | -2.74% | 955,212 | 148.00K |
| 204 | WRBY | Warby Parker Inc. | 3.04B | -1.32% | 4,091,750 | 911.61M |
| 205 | CELC | Celcuity Inc. | 2.95B | 0.67% | 2,123,433 | - |
| 206 | ATRC | AtriCure, Inc. | 2.94B | 0.84% | 850,920 | 569.62M |
| 207 | DNLI | Denali Therapeutics Inc. | 2.93B | 2.63% | 1,565,967 | 3.60M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.91B | 1.29% | 1,210,179 | 117.00M |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | -1.99% | 1,886,470 | 3.37B |
| 210 | PRVA | Privia Health Group, Inc. | 2.89B | 4.38% | 2,002,084 | 2.36B |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.88B | 0.13% | 2,053,726 | - |
| 212 | DYN | Dyne Therapeutics, Inc. | 2.86B | 1.73% | 2,074,625 | - |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.76B | 2.27% | 1,861,737 | 2.60B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.73B | 5.41% | 3,753,531 | 701.94M |
| 215 | NEOG | Neogen Corporation | 2.68B | 1.15% | 2,877,356 | 884.00M |
| 216 | TMDX | TransMedics Group, Inc. | 2.65B | 1.32% | 1,139,558 | 668.47M |
| 217 | ZLAB | Zai Lab Limited | 2.64B | 4.49% | 823,985 | 449.61M |
| 218 | PGEN | Precigen, Inc. | 2.58B | -2.18% | 3,952,551 | 85.72M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -2.22% | 204,531 | 1.46B |
| 220 | HCM | HUTCHMED (China) Limited | 2.49B | 3.41% | 51,860 | 549.12M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.49B | -2.30% | 3,368,206 | 2.48B |
| 222 | BEAM | Beam Therapeutics Inc. | 2.47B | 4.57% | 1,779,506 | 156.04M |
| 223 | NAMS | NewAmsterdam Pharma Company N.V. | 2.46B | 3.05% | 881,932 | 7.12M |
| 224 | MBX | MBX Biosciences, Inc. | 2.44B | 3.87% | 601,765 | - |
| 225 | BKD | Brookdale Senior Living Inc. | 2.41B | -0.20% | 1,277,834 | 2.93B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.40B | 3.77% | 2,766,294 | 512.28M |
| 227 | BHC | Bausch Health Companies Inc. | 2.36B | 7.13% | 397,254 | 10.85B |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.33B | 1.65% | 134,763 | 1.10B |
| 229 | UFPT | UFP Technologies, Inc. | 2.30B | 2.09% | 99,888 | 631.64M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.30B | -1.52% | 1,013,118 | 830.44M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -4.55% | 4,652,348 | - |
| 232 | PRGO | Perrigo Company plc | 2.29B | 3.32% | 1,043,325 | 4.14B |
| 233 | CLDX | Celldex Therapeutics, Inc. | 2.27B | 3.93% | 1,181,692 | 158.00K |
| 234 | RXRX | Recursion Pharmaceuticals, Inc. | 2.23B | 11.23% | 62,820,005 | 54.86M |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | 2.03% | 798,329 | 959.90M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 0.72% | 1,031,787 | 311.51M |
| 237 | NEO | NeoGenomics, Inc. | 2.22B | 2.19% | 1,315,104 | 766.30M |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.22B | 6.42% | 2,167,909 | 71.13M |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.20B | 2.59% | 109,019 | 1.95B |
| 240 | IRON | Disc Medicine, Inc. | 2.17B | 1.63% | 699,760 | - |
| 241 | FTRE | Fortrea Holdings Inc. | 2.16B | 6.58% | 2,910,262 | 2.68B |
| 242 | ADUS | Addus HomeCare Corporation | 2.13B | -0.05% | 172,421 | 1.48B |
| 243 | NVAX | Novavax, Inc. | 2.11B | 1.42% | 7,361,776 | 413.80M |
| 244 | PGNY | Progyny, Inc. | 2.11B | -1.38% | 1,057,192 | 1.31B |
| 245 | VCEL | Vericel Corporation | 2.10B | 1.91% | 601,206 | 306.30M |
| 246 | WGS | GeneDx Holdings Corp. | 2.09B | 2.35% | 788,389 | 454.43M |
| 247 | AXGN | Axogen, Inc. | 2.09B | 1.39% | 985,980 | 251.17M |
| 248 | BFLY | Butterfly Network, Inc. | 2.09B | 3.29% | 804,424 | 112.14M |
| 249 | PHVS | Pharvaris N.V. | 2.08B | -1.27% | 820,419 | - |
| 250 | VERA | Vera Therapeutics, Inc. | 2.06B | 6.84% | 1,526,516 | - |
| 251 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.05B | -0.37% | 4,503,941 | 940.61M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.03B | 3.01% | 160,237 | 898.74M |
| 253 | TRLV | Trulieve Cannabis Corp. | 1.98B | 3.31% | 1,418,650 | 1.14B |
| 254 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.73% | 283,370 | 6.13M |
| 255 | IMNM | Immunome, Inc. | 1.98B | 1.16% | 1,621,123 | 4.02M |
| 256 | ASTH | Astrana Health, Inc. | 1.95B | 0.82% | 260,477 | 3.84B |
| 257 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 4.36% | 2,048,348 | 98.34M |
| 258 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 1.67% | 227,152 | 1.13B |
| 259 | SGRY | Surgery Partners, Inc. | 1.92B | -0.40% | 2,369,455 | 3.37B |
| 260 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 4.24% | 1,093,902 | - |
| 261 | SDGR | Schrödinger, Inc. | 1.91B | 1.72% | 2,372,818 | 259.04M |
| 262 | LMAT | LeMaitre Vascular, Inc. | 1.90B | 0.80% | 297,897 | 262.43M |
| 263 | ALMR | Alamar Biosciences, Inc. | 1.90B | 8.08% | 1,260,661 | 100.42M |
| 264 | ALVO | Alvotech | 1.90B | 2.71% | 1,156,271 | 494.61M |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 5.70% | 4,041,898 | 1.97B |
| 266 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | 3.07% | 1,941,713 | 335.41M |
| 267 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | 7.94% | 2,367,226 | 208.78M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 3.88% | 240,596 | - |
| 269 | ESTA | Establishment Labs Holdings Inc. | 1.83B | 6.01% | 484,363 | 245.82M |
| 270 | ZYME | Zymeworks Inc. | 1.83B | 3.96% | 751,927 | 37.13M |
| 271 | URGN | UroGen Pharma Ltd. | 1.79B | 0.08% | 636,573 | 188.73M |
| 272 | XNCR | Xencor, Inc. | 1.78B | 2.61% | 726,917 | 104.97M |
| 273 | VIR | Vir Biotechnology, Inc. | 1.77B | 0.58% | 1,417,856 | 303.23M |
| 274 | MESO | Mesoblast Limited | 1.76B | 1.16% | 237,276 | 120.25M |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.76B | 4.62% | 5,182,762 | 3.64B |
| 276 | SEPN | Septerna, Inc. | 1.75B | 3.11% | 271,437 | 98.88M |
| 277 | BHVN | Biohaven Ltd. | 1.73B | 4.57% | 342,001 | - |
| 278 | TRVI | Trevi Therapeutics, Inc. | 1.73B | 0.41% | 1,709,229 | - |
| 279 | ARDT | Ardent Health, Inc. | 1.72B | 2.09% | 142,295 | 6.41B |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.71B | 12.60% | 405,457 | 106.73M |
| 281 | PSNL | Personalis, Inc. | 1.70B | 0.19% | 508,319 | 69.67M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.70B | 0.22% | 107,350 | 481.07M |
| 283 | ALHC | Alignment Healthcare, Inc. | 1.69B | -0.97% | 8,978,284 | 4.58B |
| 284 | ATEC | Alphatec Holdings, Inc. | 1.69B | 4.69% | 3,050,945 | 815.05M |
| 285 | NVCR | NovoCure Limited | 1.68B | 4.12% | 1,810,675 | 699.19M |
| 286 | GENB | Generate Biomedicines, Inc. | 1.68B | 4.31% | 974,901 | 26.48M |
| 287 | NUVB | Nuvation Bio Inc. | 1.67B | 1.50% | 1,208,638 | 169.90M |
| 288 | ZBIO | Zenas BioPharma, Inc. | 1.66B | 2.17% | 471,886 | 1.00M |
| 289 | OMCL | Omnicell, Inc. | 1.64B | 1.58% | 392,997 | 1.25B |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.62B | 2.50% | 3,251,884 | 52.06M |
| 291 | CMPS | COMPASS Pathways plc | 1.61B | 3.11% | 2,804,763 | - |
| 292 | AZTA | Azenta, Inc. | 1.60B | -1.78% | 1,217,354 | 613.81M |
| 293 | BRVE | Braveheart Bio, Inc. | 1.60B | 1.09% | 206,064 | - |
| 294 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -0.79% | 4,684,993 | 59.51M |
| 295 | STOK | Stoke Therapeutics, Inc. | 1.59B | 5.80% | 818,098 | 27.59M |
| 296 | GPCR | Structure Therapeutics Inc. | 1.58B | 1.42% | 1,414,109 | - |
| 297 | QURE | uniQure N.V. | 1.56B | 7.39% | 1,611,629 | 18.67M |
| 298 | AMN | AMN Healthcare Services, Inc. | 1.55B | 6.21% | 342,790 | 3.43B |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 3.02% | 240,987 | 978.38M |
| 300 | PAHC | Phibro Animal Health Corporation | 1.54B | 0.13% | 184,695 | 1.52B |
| 301 | KRSA | Korsana Biosciences, Inc. | 1.54B | -1.54% | 176,034 | - |
| 302 | MAZE | Maze Therapeutics, Inc. | 1.53B | 4.77% | 539,300 | 20.00M |
| 303 | ABSI | Absci Corporation | 1.52B | 1.60% | 3,088,915 | 1.56M |
| 304 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | 8.62% | 478,279 | - |
| 305 | IMCR | Immunocore Holdings plc | 1.52B | 4.02% | 378,197 | 430.78M |
| 306 | KLRA | Kailera Therapeutics, Inc. | 1.52B | 9.03% | 1,174,315 | - |
| 307 | INVA | Innoviva, Inc. | 1.51B | -0.52% | 672,980 | 440.00M |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | 1.81% | 3,331,965 | 717.00M |
| 309 | AGL | agilon health, inc. | 1.49B | 1.20% | 41,346 | 5.92B |
| 310 | PNTG | The Pennant Group, Inc. | 1.48B | 3.55% | 400,537 | 1.10B |
| 311 | CERT | Certara, Inc. | 1.47B | 3.21% | 1,658,185 | 421.75M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.47B | 1.95% | 124,489 | 1.86B |
| 313 | ETON | Eton Pharmaceuticals, Inc. | 1.47B | -2.93% | 462,316 | 105.60M |
| 314 | ANAB | AnaptysBio, Inc. | 1.46B | 4.37% | 416,303 | 106.09M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.19% | 2,064,136 | 746.16M |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.41B | 3.92% | 334,012 | 20.00M |
| 317 | CNMD | CONMED Corporation | 1.41B | 4.92% | 127,953 | 1.37B |
| 318 | NUTX | Nutex Health Inc. | 1.38B | 1.98% | 141,220 | 846.72M |
| 319 | OMER | Omeros Corporation | 1.36B | 1.95% | 931,363 | 38.42M |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.33B | 6.15% | 226,372 | 1.30M |
| 321 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | 10.18% | 1,557,348 | - |
| 322 | FRNM | Freenome, Inc. | 1.32B | 0.78% | 777,232 | 35.41M |
| 323 | AAPG | Ascentage Pharma Group International | 1.31B | -1.08% | 8,957 | 94.61M |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.31B | 1.82% | 418,027 | - |
| 325 | KARD | Kardigan, Inc. | 1.30B | 2.51% | 660,929 | - |
| 326 | GHRS | GH Research PLC | 1.29B | 1.35% | 276,719 | - |
| 327 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | 5.60% | 1,578,446 | - |
| 328 | NKTR | Nektar Therapeutics | 1.29B | 2.22% | 684,191 | 54.59M |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 1.26% | 64,529 | 804.27M |
| 330 | INNV | InnovAge Holding Corp. | 1.23B | -1.10% | 307,891 | 989.71M |
| 331 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 0.89% | 2,626,197 | 252.25M |
| 332 | TSHA | Taysha Gene Therapies, Inc. | 1.22B | 6.27% | 4,685,718 | 5.49M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.22B | -2.52% | 620,180 | - |
| 334 | SVRA | Savara Inc. | 1.20B | -0.42% | 419,089 | - |
| 335 | OPK | OPKO Health, Inc. | 1.20B | 17.52% | 2,930,144 | 587.90M |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.20B | 3.70% | 1,901,103 | 785.23M |
| 337 | LBRX | LB Pharmaceuticals Inc | 1.18B | 7.97% | 976,644 | - |
| 338 | CRON | Cronos Group Inc. | 1.18B | 1.27% | 244,787 | 179.09M |
| 339 | NBTX | Nanobiotix S.A. | 1.17B | 4.46% | 116,354 | 13.15M |
| 340 | BCAX | Bicara Therapeutics Inc. | 1.17B | 1.61% | 662,061 | - |
| 341 | BVS | Bioventus Inc. | 1.16B | 2.30% | 295,603 | 581.85M |
| 342 | DMRA | Damora Therapeutics, Inc. | 1.16B | 1.68% | 357,623 | - |
| 343 | AHG | Akso Health Group | 1.16B | -1.94% | 1,786 | 13.83M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 3.19% | 4,589,842 | 1.04B |
| 345 | VOR | Vor Biopharma Inc. | 1.14B | 3.15% | 696,515 | - |
| 346 | OMDA | Omada Health, Inc. | 1.14B | 2.47% | 371,415 | 309.76M |
| 347 | IRMD | IRADIMED CORPORATION | 1.14B | -0.51% | 80,632 | 86.34M |
| 348 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.12B | 1.28% | 352,330 | 730.02M |
| 349 | VSTM | Verastem, Inc. | 1.12B | 19.71% | 16,951,724 | 87.53M |
| 350 | STAA | STAAR Surgical Company | 1.12B | 1.92% | 626,106 | 339.59M |
| 351 | ENOV | Enovis Corporation | 1.12B | 4.20% | 317,403 | 2.30B |
| 352 | REPL | Replimune Group, Inc. | 1.11B | 3.16% | 1,613,633 | - |
| 353 | AVLN | Avalyn Pharma Inc. | 1.09B | 4.01% | 199,362 | - |
| 354 | TDOC | Teladoc Health, Inc. | 1.08B | 2.75% | 553,657 | 2.49B |
| 355 | HROW | Harrow, Inc. | 1.08B | 5.54% | 582,832 | 275.59M |
| 356 | AORT | Artivion, Inc. | 1.07B | 1.58% | 512,463 | 471.47M |
| 357 | CBLL | CeriBell, Inc. | 1.06B | 4.82% | 911,785 | 101.96M |
| 358 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.11% | 546,896 | 24.00M |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.05B | 2.69% | 1,334,172 | 1.65B |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | 3.66% | 1,247,805 | 337.34M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | 2.08% | 371,343 | 1.04B |
| 362 | HSTM | HealthStream, Inc. | 1.03B | 0.30% | 246,068 | 321.12M |
| 363 | CSTL | Castle Biosciences, Inc. | 1.03B | 2.08% | 381,934 | 357.28M |
| 364 | MNKD | MannKind Corporation | 1.03B | 5.63% | 3,756,527 | 393.63M |
| 365 | LTGO | Latigo Biotherapeutics, Inc. | 978.58M | 5.43% | 242,898 | - |
| 366 | IMTX | Immatics N.V. | 975.97M | 2.00% | 1,627,802 | 47.65M |
| 367 | QDEL | QuidelOrtho Corporation | 953.88M | 0.29% | 2,000,634 | 2.67B |
| 368 | MGTX | MeiraGTx Holdings plc | 948.90M | 4.99% | 836,396 | 397.50M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 943.74M | 5.70% | 164,841 | - |
| 370 | BBNX | Beta Bionics, Inc. | 911.23M | 2.61% | 1,331,131 | 119.01M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 900.97M | 2.64% | 972,108 | - |
| 372 | IAM | Iambic Therapeutics, Inc. | 896.35M | 113.43% | 438,427 | 18.25M |
| 373 | SIBN | SI-BONE, Inc. | 892.34M | 2.26% | 467,243 | 213.60M |
| 374 | AKTS | Aktis Oncology, Inc. | 890.47M | -2.91% | 667,740 | 10.06M |
| 375 | ANRO | Alto Neuroscience, Inc. | 887.66M | 4.19% | 162,557 | - |
| 376 | SLBT | SL Science Holding Limited | 883.91M | - | 130,671 | 3.27M |
| 377 | RIGL | Rigel Pharmaceuticals, Inc. | 882.62M | 0.92% | 167,848 | 276.79M |
| 378 | JBIO | Jade Biosciences, Inc. | 875.10M | 2.38% | 1,038,873 | - |
| 379 | MLTX | MoonLake Immunotherapeutics | 873.19M | 1.18% | 1,067,221 | - |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 863.37M | 2.85% | 1,543,913 | 28.73M |
| 381 | KURA | Kura Oncology, Inc. | 862.92M | 0.94% | 1,676,651 | 77.23M |
| 382 | AHCO | AdaptHealth Corp. | 852.48M | 2.24% | 1,611,358 | 3.36B |
| 383 | ABUS | Arbutus Biopharma Corporation | 848.77M | 2.39% | 2,276,548 | 181.72M |
| 384 | ODTX | Odyssey Therapeutics, Inc. | 841.93M | 5.84% | 159,238 | 99.00K |
| 385 | CRVS | Corvus Pharmaceuticals, Inc. | 828.59M | 5.01% | 1,000,121 | - |
| 386 | AVBP | ArriVent BioPharma, Inc. | 827.88M | 3.64% | 242,301 | - |
| 387 | SGP | SpyGlass Pharma, Inc. | 826.83M | 4.35% | 47,119 | - |
| 388 | INMD | InMode Ltd. | 823.12M | 0.28% | 633,854 | 374.63M |
| 389 | ALMS | Alumis Inc. | 816.74M | 4.13% | 2,786,513 | 7.40M |
| 390 | ARDX | Ardelyx, Inc. | 814.84M | 2.51% | 4,065,832 | 450.89M |
| 391 | GMRS | GMR Solutions Inc. | 807.53M | -3.08% | 135,891 | 5.88B |
| 392 | HELP | Helus Pharma Inc. | 807.31M | 6.45% | 1,521,604 | - |
| 393 | DNA | Ginkgo Bioworks Holdings, Inc. | 791.92M | 1.99% | 555,855 | 132.42M |
| 394 | GERN | Geron Corporation | 790.24M | 3.36% | 5,678,416 | 204.56M |
| 395 | ANL | Adlai Nortye Group Ltd. | 778.57M | 11.12% | 864,143 | 18.06M |
| 396 | VREX | Varex Imaging Corporation | 778.47M | 0.44% | 574,054 | 865.00M |
| 397 | APMD | Apnimed, Inc. | 759.55M | 5.89% | 260,218 | 115.12M |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 754.64M | 2.98% | 1,001,994 | 808.21M |
| 399 | OBX | Obsidian Therapeutics, Inc. | 753.63M | -0.16% | 240,297 | - |
| 400 | IVA | Inventiva S.A. | 750.45M | 8.36% | 2,906,402 | 2.81M |
| 401 | SANA | Sana Biotechnology, Inc. | 740.92M | 6.22% | 2,916,124 | - |
| 402 | LXRX | Lexicon Pharmaceuticals, Inc. | 734.18M | 3.12% | 1,433,567 | 41.47M |
| 403 | IMMX | Immix Biopharma, Inc. | 719.60M | 2.00% | 1,314,377 | - |
| 404 | ACHV | Achieve Life Sciences, Inc. | 717.23M | -0.43% | 1,197,465 | - |
| 405 | FDMT | 4D Molecular Therapeutics, Inc. | 710.99M | 5.49% | 787,560 | 92.01M |
| 406 | STLN | Starling Oncology, Inc. | 704.24M | 6.14% | 1,186,750 | 587.24M |
| 407 | CTKB | Cytek Biosciences, Inc. | 703.21M | 0.28% | 747,541 | 206.71M |
| 408 | OABI | OmniAb, Inc. | 687.70M | 3.96% | 244,520 | 38.46M |
| 409 | PHR | Phreesia, Inc. | 685.26M | 3.86% | 153,139 | 507.79M |
| 410 | PHAR | Pharming Group N.V. | 683.83M | -0.10% | 7,341 | 366.48M |
| 411 | MDXG | MiMedx Group, Inc. | 683.62M | -0.21% | 1,331,062 | 355.17M |
| 412 | ANNX | Annexon, Inc. | 682.48M | -1.91% | 2,653,845 | - |
| 413 | CADL | Candel Therapeutics, Inc. | 681.78M | -1.76% | 989,312 | - |
| 414 | GYRE | Gyre Therapeutics, Inc. | 678.62M | -1.08% | 108,762 | 109.82M |
| 415 | ATTO | Attovia Therapeutics, Inc. | 676.32M | -0.97% | 641,397 | 1.80M |
| 416 | AURA | Aura Biosciences, Inc. | 657.49M | 2.76% | 604,521 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 655.86M | 7.71% | 503,588 | - |
| 418 | AVTX | Avalo Therapeutics, Inc. | 644.10M | 1.44% | 936,784 | 59.00K |
| 419 | PRME | Prime Medicine, Inc. | 642.23M | 15.34% | 608,663 | 4.07M |
| 420 | WVE | Wave Life Sciences, Inc. | 628.58M | 3.24% | 3,350,887 | 65.37M |
| 421 | CLYM | Climb Bio, Inc. | 626.63M | 6.03% | 515,480 | - |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 622.95M | 4.72% | 2,044,781 | 389.32M |
| 423 | SOPH | SOPHiA GENETICS SA | 620.58M | 3.26% | 1,754,578 | 86.17M |
| 424 | AVR | Anteris Technologies Global Corp. | 620.06M | 1.60% | 825,617 | 2.24M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 616.77M | 5.17% | 156,861 | - |
| 426 | SLDB | Solid Biosciences Inc. | 615.47M | 5.03% | 2,033,369 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 609.87M | 0.39% | 462,444 | 136.07M |
| 428 | PACB | Pacific Biosciences of California, Inc. | 609.23M | -1.51% | 12,620,710 | 159.27M |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 601.11M | 1.03% | 1,088,435 | - |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 595.73M | 1.35% | 1,210,168 | 239.66M |
| 431 | WEAV | Weave Communications, Inc. | 591.19M | - | 176,198 | 257.79M |
| 432 | KIDS | OrthoPediatrics Corp. | 589.30M | 1.44% | 225,699 | 252.72M |
| 433 | FLGT | Fulgent Genetics, Inc. | 587.18M | 1.57% | 139,673 | 323.93M |
| 434 | CRMD | CorMedix Inc. | 581.46M | 0.95% | 1,466,190 | 462.25M |
| 435 | SGMT | Sagimet Biosciences Inc. | 579.32M | 8.28% | 1,366,994 | - |
| 436 | VALN | Valneva SE | 573.48M | 4.42% | 8,655 | 163.30M |
| 437 | SLN | Silence Therapeutics plc | 562.96M | 4.12% | 2,567,485 | 615.00K |
| 438 | STTK | Shattuck Labs, Inc. | 555.01M | 3.75% | 867,810 | 1.00M |
| 439 | DBVT | DBV Technologies S.A. | 552.62M | 2.71% | 432,283 | 5.04M |
| 440 | EVH | Evolent Health, Inc. | 550.60M | 2.96% | 970,896 | 2.10B |
| 441 | ETRA | Electra Therapeutics, Inc. | 549.21M | -2.13% | 179,539 | - |
| 442 | PBYI | Puma Biotechnology, Inc. | 543.04M | 3.14% | 377,412 | 231.24M |
| 443 | CBIO | Crescent Biopharma, Inc. | 534.16M | -0.79% | 294,952 | 11.88M |
| 444 | FTH | Faeth Therapeutics, Inc. | 532.31M | 3.00% | 231,649 | - |
| 445 | TCMD | Tactile Systems Technology, Inc. | 527.57M | 3.93% | 211,387 | 350.31M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 525.14M | 8.07% | 2,985,209 | 18.30M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 524.39M | 6.90% | 121,449 | - |
| 448 | SSII | SS Innovations International, Inc. | 516.99M | -4.44% | 29,086 | 52.40M |
| 449 | DCTH | Delcath Systems, Inc. | 513.89M | 0.61% | 214,860 | 95.42M |
| 450 | ACRS | Aclaris Therapeutics, Inc. | 513.72M | 3.25% | 2,587,372 | 8.22M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 509.58M | -11.93% | 5,466,967 | 54.09M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 453 | EVO | Evotec SE | 500.06M | -0.35% | 123,975 | 819.47M |
| 454 | EOLS | Evolus, Inc. | 500.00M | 4.85% | 901,455 | 316.49M |
| 455 | MASS | 908 Devices Inc. | 491.46M | 0.51% | 274,626 | 60.84M |
| 456 | ANGO | AngioDynamics, Inc. | 486.99M | 4.80% | 1,136,940 | 325.38M |
| 457 | SGHT | Sight Sciences, Inc. | 484.77M | 6.67% | 282,037 | 83.38M |
| 458 | MNPR | Monopar Therapeutics Inc. | 481.93M | -1.78% | 140,931 | - |
| 459 | ENTX | Entera Bio Ltd. | 481.77M | 10.80% | 1,447,710 | 42.00K |
| 460 | NGNE | Neurogene Inc. | 479.27M | 7.98% | 587,982 | 925.00K |
| 461 | YDES | YD Bio Limited | 477.40M | 5.97% | 72,321 | 1.24M |
| 462 | BLSM | BlossomHill Therapeutics, Inc. | 475.50M | -1.97% | 176,511 | - |
| 463 | RGNX | REGENXBIO Inc. | 472.65M | 4.07% | 1,228,347 | 174.48M |
| 464 | TLRY | Tilray Brands, Inc. | 470.79M | 2.23% | 2,669,688 | 963.10M |
| 465 | ARVN | Arvinas, Inc. | 468.17M | 4.99% | 604,841 | 316.70M |
| 466 | NRC | NRC Health | 466.94M | 3.33% | 98,468 | 140.00M |
| 467 | KMDA | Kamada Ltd. | 466.54M | 3.03% | 60,981 | 191.85M |
| 468 | BWAY | BrainsWay Ltd. | 465.93M | 2.69% | 109,588 | 60.70M |
| 469 | ALLO | Allogene Therapeutics, Inc. | 462.96M | 3.08% | 770,398 | 4.64M |
| 470 | ALT | Altimmune, Inc. | 459.06M | 2.16% | 3,346,237 | 31.00K |
| 471 | AUTL | Autolus Therapeutics plc | 457.80M | 1.78% | 1,486,108 | 117.39M |
| 472 | OCS | Oculis Holding AG | 456.82M | 3.21% | 559,160 | 1.45M |
| 473 | CERS | Cerus Corporation | 455.45M | 0.89% | 2,166,801 | 221.55M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.05M | 2.73% | 297,259 | - |
| 475 | MPLT | MapLight Therapeutics, Inc. | 445.72M | 2.69% | 658,421 | - |
| 476 | OVID | Ovid Therapeutics Inc. | 441.37M | 3.20% | 1,333,228 | 1.58M |
| 477 | PROK | ProKidney Corp. | 439.88M | -1.02% | 1,107,512 | 818.00K |
| 478 | NPCE | NeuroPace, Inc. | 438.66M | 1.75% | 86,609 | 106.99M |
| 479 | PRTA | Prothena Corporation plc | 436.36M | 1.55% | 358,336 | 54.53M |
| 480 | SENS | Senseonics Holdings, Inc. | 435.15M | 1.60% | 678,190 | 48.55M |
| 481 | DMAC | DiaMedica Therapeutics Inc. | 433.56M | 4.96% | 303,894 | - |
| 482 | CAPR | Capricor Therapeutics, Inc. | 422.67M | 10.32% | 3,354,037 | 11.13M |
| 483 | ASMB | Assembly Biosciences, Inc. | 418.82M | 0.19% | 204,161 | 74.85M |
| 484 | TECX | Tectonic Therapeutic, Inc. | 416.40M | 1.62% | 187,390 | - |
| 485 | MYGN | Myriad Genetics, Inc. | 416.08M | 4.82% | 1,068,857 | 806.60M |
| 486 | RCEL | AVITA Medical, Inc. | 414.73M | 2.37% | 120,941 | 75.63M |
| 487 | AGMB | AgomAb Therapeutics NV | 410.24M | -4.14% | 90,912 | - |
| 488 | ZURA | Zura Bio Limited | 410.15M | -2.95% | 4,995,820 | - |
| 489 | RZLT | Rezolute, Inc. | 409.10M | -7.80% | 2,120,174 | - |
| 490 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 7.56% | 657,042 | - |
| 491 | TKNO | Alpha Teknova, Inc. | 408.03M | -2.44% | 353,080 | 43.70M |
| 492 | CYH | Community Health Systems, Inc. | 405.23M | 0.34% | 190,703 | 11.98B |
| 493 | SPRY | ARS Pharmaceuticals, Inc. | 404.75M | 3.56% | 2,220,029 | 116.93M |
| 494 | CTEV | Claritev Corporation | 404.37M | -0.33% | 102,249 | 994.67M |
| 495 | AUNA | Auna S.A. | 392.27M | 0.95% | 44,811 | 1.37B |
| 496 | SCTX | Scribe Therapeutics Inc. | 392.26M | -0.24% | 180,843 | 33.30M |
| 497 | OFIX | Orthofix Medical Inc. | 390.63M | 3.68% | 317,972 | 833.19M |
| 498 | SRTA | Strata Critical Medical, Inc. | 383.95M | 1.40% | 194,391 | 255.98M |
| 499 | SI | Shoulder Innovations, Inc. | 382.44M | 2.80% | 25,180 | 60.06M |
| 500 | TRXB | TRex Bio, Inc. | 381.22M | 4.89% | 88,625 | - |